Furthermore, COX-2, in particular the downstream product prostaglandin E2 (PGE2), is able to promote carcinogenesis and progression in different cancer types, such as skin, breast, colon, and lung cancer, that are associated with poor prognosis [2,15,20,21,22]. Here, PTGS2 is linked to cancer.